What is Celldex Therapeutics's AOCI?

Celldex Therapeutics (CLDX) reported AOCI of $2.52M in Q1 2026.

How has Celldex Therapeutics's AOCI changed year-over-year?

Celldex Therapeutics's AOCI decreased by 29.3% year-over-year, from $3.57M to $2.52M.

What is the long-term trend for Celldex Therapeutics's AOCI?

Over 5 years (2020 to 2025), Celldex Therapeutics's AOCI has grown at a 7.0% compound annual growth rate (CAGR), from $2.59M to $3.63M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Celldex Therapeutics CLDX AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

PfizerPFE

-$7.2B+16.1%

Rogers CorporationROG

-$55M+29.1%

AmgenAMGN

-$190M+17.7%

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

IncyteINCY

$22.31M+458%

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's AOCI?: Celldex Therapeutics (CLDX) reported AOCI of $2.52M in Q1 2026.
How has Celldex Therapeutics's AOCI changed year-over-year?: Celldex Therapeutics's AOCI decreased by 29.3% year-over-year, from $3.57M to $2.52M.
What is the long-term trend for Celldex Therapeutics's AOCI?: Over 5 years (2020 to 2025), Celldex Therapeutics's AOCI has grown at a 7.0% compound annual growth rate (CAGR), from $2.59M to $3.63M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.